Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BCB BANCORP INCBCBP · Entity 6510 | Director | March 14, 2018 | March 14, 2018 |
| Canton Strategic Holdings, Inc.CNTN · Entity 6394 | Director | May 22, 2026 | May 27, 2026 |
| Hepion Pharmaceuticals, Inc.HEPA · Entity 8208 | Director · Interim CEO | August 19, 2026 | August 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BCB BANCORP INC
Report date March 14, 2018 · Filed March 14, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 12,000 |
Reported balance
After 2018-03-14 transaction · row 1
1 source rowRow 1 · 2018-03-14 · Purchase · Acquired 500 · Balance 12,000 |
| Common StockSEC Table I · non-derivative | IndirectPension Plan | 42,202 |
Reported balance
Holding disclosure · report date 2018-03-14 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 42,202 |
| Common StockSEC Table I · non-derivative | IndirectBy Son | 2,777 |
Reported balance
Holding disclosure · report date 2018-03-14 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 2,777 |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $12.40 · Expires 2027-09-13 | Direct | 25,000 |
Reported balance
Holding disclosure · report date 2018-03-14 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 25,000 |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $10.92 · Expires 2026-09-16 | Direct | 10,000 |
Reported balance
Holding disclosure · report date 2018-03-14 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 10,000 |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $10.78 · Expires 2025-12-03 | Direct | 10,000 |
Reported balance
Holding disclosure · report date 2018-03-14 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 10,000 |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $9.03 · Expires 2023-01-17 | Direct | 10,000 |
Reported balance
Holding disclosure · report date 2018-03-14 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 10,000 |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $13.32 · Expires 2024-03-07 | Direct | 10,000 |
Reported balance
Holding disclosure · report date 2018-03-14 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 10,000 |
Canton Strategic Holdings, Inc.
Report date May 22, 2026 · Filed May 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 134,175 |
Ending reported balance
After 2026-05-26 transaction · row 8
8 source rows · reconciled sequenceRow 1 · 2026-05-22 · Sale · Disposed 10,000 · Balance 224,526 Row 2 · 2026-05-22 · Sale · Disposed 10,000 · Balance 214,526 Row 3 · 2026-05-22 · Sale · Disposed 15,000 · Balance 199,526 Row 4 · 2026-05-22 · Sale · Disposed 15,000 · Balance 184,526 Row 5 · 2026-05-22 · Sale · Disposed 15,000 · Balance 169,526 Row 6 · 2026-05-22 · Sale · Disposed 10,000 · Balance 159,526 Row 7 · 2026-05-22 · Sale · Disposed 12,851 · Balance 146,675 Row 8 · 2026-05-26 · Sale · Disposed 12,500 · Balance 134,175 |
Hepion Pharmaceuticals, Inc.
Report date August 19, 2026 · Filed August 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $0.08 · Expires 2036-08-19 | Direct | 1,345,500 |
Reported balance
After 2026-08-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-08-19 · Grant · Acquired 1,345,500 · Balance 1,345,500 F1: 336,375 options vest upon grant and the remaining amount vests in equal amounts monthly over 6 months from date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: 336,375 options vest upon grant and the remaining amount vests in equal amounts monthly over 6 months from date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 19, 2026 Filed Aug 21, 2026 20:36 UTC | Hepion Pharmaceuticals, Inc. HEPA · Entity 8208 | GrantStock Options · Derivative | 1,345,500 | $0.00 Strike: $0.08 | $0.00 |
DisclosureSEC source: 0001493152-26-039705 · ownership.xml · derivative · entry 1 Stetz Gary S. · CIK 0001532793 · Director · Interim CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,345,500 Underlying: Common Stock · 1,345,500 shares Expires 2036-08-19 F1 · derivative.exercise_date: 336,375 options vest upon grant and the remaining amount vests in equal amounts monthly over 6 months from date of grant. Read SEC document |
| August 03, 2026 Filed Aug 13, 2026 01:41 UTC | Hepion Pharmaceuticals, Inc. HEPA · Entity 8208 | PurchaseWarrants · Derivative | 2,000,000 | $0.00 Strike: $0.06 | $0.00 |
DisclosureSEC source: 0001493152-26-037496 · ownership.xml · derivative · entry 2 Stetz Gary S. · CIK 0001532793 · Director · Interim CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,000,000 Underlying: Common Stock · 2,000,000 shares Expires 2031-08-03 Read SEC document |
| August 03, 2026 Filed Aug 13, 2026 01:41 UTC | Hepion Pharmaceuticals, Inc. HEPA · Entity 8208 | PurchaseCommon Stock | 2,000,000 | $0.05 | $100,000.00 |
DisclosureSEC source: 0001493152-26-037496 · ownership.xml · nonDerivative · entry 1 Stetz Gary S. · CIK 0001532793 · Director · Interim CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,250,000 Read SEC document |
| May 26, 2026 Filed May 27, 2026 22:35 UTC | Canton Strategic Holdings, Inc. CNTN · Entity 6394 | SaleCommon Stock | 12,500 | $3.47 | $43,375.00 |
DisclosureSEC source: 0001493152-26-025469 · ownership.xml · nonDerivative · entry 8 Stetz Gary S. · CIK 0001532793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,175 Read SEC document |
| May 22, 2026 Filed May 27, 2026 22:35 UTC | Canton Strategic Holdings, Inc. CNTN · Entity 6394 | SaleCommon Stock | 12,851 | $3.44 | $44,207.44 |
DisclosureSEC source: 0001493152-26-025469 · ownership.xml · nonDerivative · entry 7 Stetz Gary S. · CIK 0001532793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,675 Read SEC document |
| May 22, 2026 Filed May 27, 2026 22:35 UTC | Canton Strategic Holdings, Inc. CNTN · Entity 6394 | SaleCommon Stock | 10,000 | $3.40 | $34,000.00 |
DisclosureSEC source: 0001493152-26-025469 · ownership.xml · nonDerivative · entry 6 Stetz Gary S. · CIK 0001532793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 159,526 Read SEC document |
| May 22, 2026 Filed May 27, 2026 22:35 UTC | Canton Strategic Holdings, Inc. CNTN · Entity 6394 | SaleCommon Stock | 15,000 | $3.41 | $51,150.00 |
DisclosureSEC source: 0001493152-26-025469 · ownership.xml · nonDerivative · entry 5 Stetz Gary S. · CIK 0001532793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,526 Read SEC document |
| May 22, 2026 Filed May 27, 2026 22:35 UTC | Canton Strategic Holdings, Inc. CNTN · Entity 6394 | SaleCommon Stock | 15,000 | $3.41 | $51,150.00 |
DisclosureSEC source: 0001493152-26-025469 · ownership.xml · nonDerivative · entry 4 Stetz Gary S. · CIK 0001532793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 184,526 Read SEC document |
| May 22, 2026 Filed May 27, 2026 22:35 UTC | Canton Strategic Holdings, Inc. CNTN · Entity 6394 | SaleCommon Stock | 15,000 | $3.40 | $51,000.00 |
DisclosureSEC source: 0001493152-26-025469 · ownership.xml · nonDerivative · entry 3 Stetz Gary S. · CIK 0001532793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 199,526 Read SEC document |
| May 22, 2026 Filed May 27, 2026 22:35 UTC | Canton Strategic Holdings, Inc. CNTN · Entity 6394 | SaleCommon Stock | 10,000 | $3.45 | $34,500.00 |
DisclosureSEC source: 0001493152-26-025469 · ownership.xml · nonDerivative · entry 2 Stetz Gary S. · CIK 0001532793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 214,526 Read SEC document |
| May 22, 2026 Filed May 27, 2026 22:35 UTC | Canton Strategic Holdings, Inc. CNTN · Entity 6394 | SaleCommon Stock | 10,000 | $3.45 | $34,500.00 |
DisclosureSEC source: 0001493152-26-025469 · ownership.xml · nonDerivative · entry 1 Stetz Gary S. · CIK 0001532793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 224,526 Read SEC document |
| April 21, 2026 Filed Apr 27, 2026 10:24 UTC | Hepion Pharmaceuticals, Inc. HEPA · Entity 8208 | PurchaseCommon Stock, par value $0.0001 per share | 1,250,000 | $0.04 | $50,000.00 |
DisclosureSEC source: 0001493152-26-019027 · ownership.xml · nonDerivative · entry 1 Stetz Gary S. · CIK 0001532793 · Director · Interim CEO 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 1,250,000 F1 · ownership.nature: Through Stetz Belgiovine CPA 401K F/B/O Gary S. Stetz Read SEC document |
| November 03, 2025 Filed Nov 6, 2025 01:57 UTC | Canton Strategic Holdings, Inc. THAR · Entity 6394 | GrantStock Option · Derivative | 32,500 | $0.00 Strike: $3.08 | $0.00 |
DisclosureSEC source: 0001493152-25-020938 · ownership.xml · derivative · entry 1 Stetz Gary S. · CIK 0001532793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,500 Underlying: Common Stock · 32,500 shares Expires 2035-11-03 Read SEC document |
| March 14, 2018 Filed Mar 14, 2018 19:09 UTC | BCB BANCORP INC BCBP · Entity 6510 | PurchaseCommon Stock | 500 | $15.80 | $7,900.00 |
DisclosureSEC source: 0001140361-18-013417 · doc1.xml · nonDerivative · entry 1 Stetz Gary S. · CIK 0001532793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Read SEC document |
| October 25, 2017 Filed Oct 25, 2017 20:14 UTC | BCB BANCORP INC BCBP · Entity 6510 | PurchaseCommon Stock | 250 | $14.50 | $3,625.00 |
DisclosureSEC source: 0001140361-17-039542 · doc1.xml · nonDerivative · entry 2 Stetz Gary S. · CIK 0001532793 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Pension Plan Disclosed balance after: 36,911 Read SEC document |
| October 25, 2017 Filed Oct 25, 2017 20:14 UTC | BCB BANCORP INC BCBP · Entity 6510 | PurchaseCommon Stock | 1,500 | $14.60 | $21,900.00 |
DisclosureSEC source: 0001140361-17-039542 · doc1.xml · nonDerivative · entry 1 Stetz Gary S. · CIK 0001532793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,500 Read SEC document |
| September 13, 2017 Filed Sep 14, 2017 21:21 UTC | BCB BANCORP INC BCBP · Entity 6510 | GrantStock Options · Derivative | 25,000 | $0.00 Strike: $12.40 | $0.00 |
DisclosureSEC source: 0001140361-17-035554 · doc1.xml · derivative · entry 4 Stetz Gary S. · CIK 0001532793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2027-09-13 F1 · derivative.underlying_shares: Stock options vest at a rate of 10% per year commencing on September 13, 2018. Read SEC document |
| September 12, 2017 Filed Sep 14, 2017 21:21 UTC | BCB BANCORP INC BCBP · Entity 6510 | PurchaseCommon Stock | 10,000 | $12.25 | $122,500.00 |
DisclosureSEC source: 0001140361-17-035554 · doc1.xml · nonDerivative · entry 1 Stetz Gary S. · CIK 0001532793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Read SEC document |
| June 20, 2017 Filed Jun 20, 2017 20:24 UTC | BCB BANCORP INC BCBP · Entity 6510 | PurchaseCommon Stock | 250 | $15.50 | $3,875.00 |
DisclosureSEC source: 0001140361-17-025585 · doc1.xml · nonDerivative · entry 1 Stetz Gary S. · CIK 0001532793 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Pension Plan Disclosed balance after: 36,661 Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 20:01 UTC | BCB BANCORP INC BCBP · Entity 6510 | PurchaseCommon Stock | 725 | $12.94 | $9,384.76 |
DisclosureSEC source: 0001140361-16-090211 · doc1.xml · nonDerivative · entry 1 Stetz Gary S. · CIK 0001532793 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Pension Plan Disclosed balance after: 36,411 Read SEC document |
| September 16, 2016 Filed Sep 20, 2016 19:04 UTC | BCB BANCORP INC BCBP · Entity 6510 | GrantStock Options · Derivative | 10,000 | $0.00 Strike: $10.92 | $0.00 |
DisclosureSEC source: 0001140361-16-080284 · doc1.xml · derivative · entry 3 Stetz Gary S. · CIK 0001532793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2026-09-16 F1 · shares: Stock options vest at a rate of 10% per year commencing on September 16, 2017. F1 · derivative.underlying_shares: Stock options vest at a rate of 10% per year commencing on September 16, 2017. F1 · balance_after: Stock options vest at a rate of 10% per year commencing on September 16, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.